EGFR and non-small cell lung carcinoma: Although further studies are required to confirm these observations, the identification of global copy number changes in liquid biopsies might early indicate resistance development in EGFR TKI treated NSCLC patients, indicating the requirement for tissue rebiopsy to eventually confirm SCLC transformation.